As in the recent study, Lavainne et al. [21] indicated that heparin-based HD induced a major release of sFlt1, a potent inhibitor of vascular endothelial growth factor, which may exacerbate the anti-angiogenic state and thus endothelial dysfunction, commonly found in dialysis patients. This evidence concerns the gene VEGFA and endothelial dysfunction.